“…The occurrence of PsA has been estimated at between 6% and 42% of patients afflicted with psoriasis [2][3][4][5][6], which occurs in 1-3% of the population [7][8][9]. The clinical manifestations of PsA include arthritis, enthesitis, dactylitis, spondylitis, psoriasis, and nail disease, with approximately 50% of patients also experiencing erosive joint damage within the first 2 years [10].…”